SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Protect Pharmaceutical Corporation (PRTT) 当前追踪市盈率 (P/E) 为 0.1. 追踪盈利收益率为 2,000.00%.
本页证实的标准:
- VALUE (100/100, 通过) — 市盈率低于市场平均水平 (0.1); 盈利收益率超过债券收益率 (2,000.00%).
- 追踪盈利收益率 2,000.00% — 超过典型债券收益率(约4.3%),使股票相对固定收益更具吸引力。
SharesGrow 综合评分: 90/100 其中 5/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
✓
健康
100/100
Debt-to-Equity & liquidity
→ Health
估值概览 — PRTT
估值倍数
P/E (TTM)0.1
前瞻 P/EN/A
PEG 比率0.00
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.02
EV/EBITDA0.0
每股数据
EPS (TTM)$0.98
每股账面价值$0.00
每股营收$2.30
每股自由现金流$0.00
收益率与内在价值
盈利收益率2,000.00%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS(稀释) |
营收 |
净利润 |
净利润率 |
| 2014 |
$8.48 |
$0.00 |
$458.15K |
- |
| 2015 |
$-1.44 |
$0.00 |
$-635K |
- |
| 2016 |
$-0.04 |
$0.00 |
$-41.71K |
- |
| 2017 |
$-0.10 |
$0.00 |
$-123K |
- |
| 2019 |
$0.00 |
$0.00 |
$-1.87K |
- |
| 2020 |
$0.11 |
$5.94M |
$5.81M |
97.8% |
| 2021 |
$0.36 |
$78.79M |
$20.21M |
25.6% |
| 2022 |
$0.43 |
$81.8M |
$22.44M |
27.4% |
| 2023 |
$0.80 |
$136.16M |
$45.91M |
33.7% |
| 2024 |
$0.98 |
$132.26M |
$56.33M |
42.6% |